0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > CLEC3B

CLEC3B

Brief Information

Name:Tenascin
Target Synonym:Glioma-associated-extracellular matrix antigen,GMEM,Neuronectin,Hexabrachion,Tenascin-C,TN-C,GP 150-225,TNC,Tenascin C,Deafness, Autosomal Dominant 56,Hexabrachion (Tenascin),Myotendinous Antigen,Cytotactin,HXB,JI,TN,Hexabrachion (Tenascin C, Cytotactin),Tenascin-C Additional Domain 1,Tenascin-C Isoform 14/AD1/16,150-225,DFNA56,GP,Tenascin,MGC167029
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Discontinued

Product Inquiry

* We couldn't find what you're looking for. You can let us help by filling the form below. Our tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information will be kept strictly confidential.
Product inquiry collection form
*
*
*
*
*
*
*
*
*
ACRO Quality

Synonym Name

CLEC3B,Tetranectin,TN,TNA

Background

C-type lectin domain family 3 member B (CLEC3B) is also known as Tetranectin, Plasminogen kringle 4-binding protein, is a secreted homotrimer. CLEC3B contains 1 C-type lectin domain and mainly found in plasma. Tetranectin / CLEC3B binds to plasminogen and to isolated kringle 4. CLEC3B may be involved in the packaging of molecules destined for exocytosis. Decreased plasma Tetranectin or increased Tetranectin in stroma of cancers correlates with cancer progression and adverse prognosis.

Clinical and Translational Updates

This web search service is supported by Google Inc.

totop

Nachricht schicken